Boston Scientific (BSX) Other financing activities (2024 - 2026)

Boston Scientific has disclosed Other financing activities across 3 years of filings, most recently posting $3.0 million for Q1 2026.

• Other financing activities for Q1 2026 came in at $3.0 million, up 130.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.0 million (up 400.0% YoY), and the FY2025 annual result was $7.0 million, up 800.0% from the prior year.
• Other financing activities came in at $3.0 million for Q1 2026 at Boston Scientific, down from $9.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $11.0 million in Q3 2024 to a low of -$10.0 million in Q1 2025.
• The 3-year median for Other financing activities is $3.0 million (2024), against an average of $3.4 million.
• Peak annual rise in Other financing activities reached 200.0% in 2025, while the deepest fall reached 109.09% in 2025.
• Boston Scientific's Other financing activities stood at $3.0 million in 2024, then soared by 200.0% to $9.0 million in 2025, then slumped by 66.67% to $3.0 million in 2026.
• The last three Other financing activities figures came in at $3.0 million (Q1 2026), $9.0 million (Q4 2025), and -$1.0 million (Q3 2025), per Business Quant data.